Trust Co decreased its holdings in Humana Inc (NYSE:HUM) by 9.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,157 shares of the insurance provider’s stock after selling 213 shares during the period. Trust Co’s holdings in Humana were worth $526,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Humana by 1.6% in the second quarter. Vanguard Group Inc. now owns 9,892,635 shares of the insurance provider’s stock valued at $2,380,366,000 after buying an additional 157,868 shares during the period. FMR LLC raised its stake in Humana by 29.3% in the second quarter. FMR LLC now owns 6,530,063 shares of the insurance provider’s stock valued at $1,571,264,000 after buying an additional 1,479,210 shares during the period. Capital Research Global Investors raised its stake in Humana by 9.7% in the second quarter. Capital Research Global Investors now owns 3,907,333 shares of the insurance provider’s stock valued at $940,182,000 after buying an additional 346,069 shares during the period. Renaissance Technologies LLC raised its stake in Humana by 1.5% in the second quarter. Renaissance Technologies LLC now owns 2,731,100 shares of the insurance provider’s stock valued at $657,157,000 after buying an additional 39,400 shares during the period. Finally, Janus Henderson Group PLC raised its stake in Humana by 74.1% in the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after buying an additional 1,161,661 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

A number of equities analysts have recently weighed in on HUM shares. Credit Suisse Group lowered their target price on Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research note on Friday, November 10th. ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. BMO Capital Markets started coverage on Humana in a research note on Monday, October 16th. They set an “outperform” rating and a $300.00 target price on the stock. Goldman Sachs Group started coverage on Humana in a research note on Wednesday, January 3rd. They set a “buy” rating and a $305.00 target price on the stock. Finally, Zacks Investment Research lowered Humana from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 17th. Eleven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $260.70.

In other Humana news, SVP Jody L. Bilney sold 7,054 shares of the firm’s stock in a transaction on Monday, December 18th. The stock was sold at an average price of $247.89, for a total value of $1,748,616.06. Following the sale, the senior vice president now owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Timothy S. Huval sold 1,382 shares of the firm’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the sale, the vice president now directly owns 11,557 shares in the company, valued at approximately $2,843,484.28. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,115 shares of company stock worth $2,501,627. Corporate insiders own 0.80% of the company’s stock.

Humana Inc (NYSE:HUM) traded up $0.02 during trading on Thursday, reaching $263.10. The company’s stock had a trading volume of 928,400 shares, compared to its average volume of 1,144,000. Humana Inc has a 12-month low of $186.25 and a 12-month high of $264.90. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market cap of $37,990.00, a price-to-earnings ratio of 20.72, a PEG ratio of 1.74 and a beta of 0.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The firm had revenue of $13.28 billion for the quarter, compared to analyst estimates of $13.41 billion. During the same quarter last year, the company earned $3.18 EPS. The company’s revenue was down 3.0% on a year-over-year basis. equities analysts expect that Humana Inc will post 11.63 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.61%. Humana’s dividend payout ratio (DPR) is presently 12.60%.

Humana announced that its Board of Directors has authorized a share buyback plan on Thursday, December 14th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the insurance provider to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.

WARNING: “Humana Inc (HUM) Shares Sold by Trust Co” was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.watchlistnews.com/humana-inc-hum-shares-sold-by-trust-co/1803133.html.

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.